Skip to content
For Dogs · WOOPF™, opens in a new tabCare about your pet? Download ASK A VET!For Cats · PURRZ™, opens in a new tab
ASK A VET
Veterinary Guide to Canine IMHA (Immune-Mediated Hemolytic Anemia) 🩺🐶
All articles
Ask A Vet
  • Exotic Animal Care
  • Large Animal Care
  • Nutrition
  • Pet Care
  • Tech & Tracking
  • Vet Tips

Veterinary Guide to Canine IMHA (Immune-Mediated Hemolytic Anemia) 🩺🐶

Summary of Canine Immune-Mediated Hemolytic Anemia (IMHA) 2025 🩺🐶 Immune-Mediated Hemolytic Anemia (IMHA) is a serious autoimmune disorder in which a dog’s immune system destroys its red blood cells, leading to severe anemia, poor oxygenation, and possible organ damage. Symptoms include lethargy, jaundice, weakness, and dark urine. There are two types: primary (idiopathic) and secondary (triggered by infections, drugs, toxins, or neoplasia). Diagnosis involves CBC, Coombs test, and imaging. Treatment focuses on blood transfusions, high-dose corticosteroids, and managing secondary causes. Long-term monitoring is crucial as relapse rates are common. Prognosis varies, with short-term mortality being high but long-term survival achievable with appropriate care. Dr. Duncan Houston BVSc, 2025

Duncan Houston
Duncan Houston
Veterinarian · Founder of ASK A VET
7 min read

Veterinary Guide to Canine IMHA 2025 🩺🐶

By Dr. Duncan Houston BVSc

🧬 What Is IMHA?

Immune-Mediated Hemolytic Anemia (IMHA) occurs when a dog’s immune system attacks its own red blood cells (RBCs), leading to severe anemia, poor oxygenation, and potentially organ damage—making it a life-threatening emergency.

👥 Primary vs Secondary IMHA

  • Primary (idiopathic): ~75% of cases, no underlying trigger found.
  • Secondary: occurs secondary to infection (Babesia, Ehrlichia, etc.), neoplasia, drugs (NSAIDs, penicillin, vaccines), toxins, or inflammatory diseases.

👀 Common Signs & Presentation

  • Lethargy, exercise intolerance, weakness, and collapse.
  • Pale or jaundiced gums due to hemolysis.
  • Increased heart and respiratory rates; breathlessness.
  • Dark urine from hemoglobinuria; vomiting and anorexia.
  • Splenomegaly or hepatomegaly may be present
  • Acute collapse/jaundice in intravascular hemolysis cases.

⚙️ Pathophysiology

Antibodies (and sometimes complement) target RBCs, which are destroyed in the spleen/liver (extravascular) or directly within blood vessels (intravascular), releasing hemoglobin into the bloodstream. Lab findings include spherocytosis, autoagglutination, and polychromasia due to bone marrow regeneration.

🔬 Diagnostic Workflow

  1. Physical exam: pale/jaundiced mucous membranes, tachycardia, respiratory distress.
  2. CBC: regenerative anemia (low PCV/HCT, high reticulocytes), spherocytes, autoagglutination.
  3. Coombs test or slide agglutination: confirms immune-mediated RBC destruction.
  4. Chemistry + urinalysis: evaluate organ function and detect hemoglobinuria.
  5. Imaging and infectious disease screening: chest/abdomen imaging and tests for Babesia, Ehrlichia, etc. to detect secondary causes.

🛠️ Treatment Strategies

🏥 Hospitalization & Supportive Care

  • Blood transfusion: to stabilize anemia and oxygen levels.
  • IV fluids: support circulation and prevent kidney injury.
  • Oxygen therapy: if respiratory distress is present.

💊 Immunosuppression & Adjunctive Drugs

  • High-dose corticosteroids (prednisone/prednisolone) – cornerstone therapy.
  • Second-line agents: azathioprine, cyclosporine, mycophenolate to reduce steroid dependence.
  • Anticoagulation: clopidogrel or aspirin to reduce the risk of thromboembolism.
  • Address secondary causes: antibiotics for infections, chemo for neoplasia.

🩺 Monitoring Progress

  • Daily PCV checks during the acute phase; adjust meds accordingly.
  • Monitor for transfusion reactions, infections, and steroid side effects.
  • Periodic ultrasound/X-rays and infectious disease testing if underlying causes are identified.

📈 Prognosis & Long-Term Outlook

  • Short-term mortality ranges from ~26% to 70%, often due to anemia or thromboembolic events.
  • Factors linked to poorer prognosis: thrombocytopenia, high bilirubin, and renal dysfunction.
  • Long-term survival (beyond 3 months) possible: 2664 days reported for non-associative cases.
  • Relapse rates ~7–15%; lifelong monitoring often necessary.

🏥 At‑Home & Ongoing Care

  • Gradual tapering of immunosuppressives and transfusion support as directed.
  • Regular CBC/PCV checks: weekly → monthly → quarterly.
  • Continue anticoagulation to prevent clots, if advised.
  • Watch for relapse: pale gums, lethargy, dark urine—seek vet promptly.

📱 Ask A Vet Telehealth Integration

  • Remote vet video evaluations: owners show gum color, behavior, and breathing.
  • Lab reminders: App alerts for blood tests and rechecks.
  • Medication scheduling: Helps track steroids and immunosuppressives.

🎓 Case Spotlight: “Ruby” the Cocker Spaniel

Ruby, a 5-year-old Cocker Spaniel, presented with pale gums, lethargy, tachycardia, and dark urine. CBC showed HCT 15%, spherocytes, and positive Coombs. She received two transfusions, high-dose steroids plus mycophenolate, and clopidogrel. After 10 days in the hospital, she returned home on tapering meds. One month later, her PCV was normal, and she transitioned to maintenance therapy. With Ask A Vet’s lab reminders and medication scheduling, Ruby remains in remission 18 months later 🐕❤️.

🔚 Key Takeaways

  1. IMHA is a medical emergency—early recognition and stabilization save lives.
  2. Primary (idiopathic) and secondary causes both occur—investigate thoroughly.
  3. Multimodal therapy: transfusions, immunosuppression, and anticoagulation are essential.
  4. Mortality is high early on; long-term survival is achievable with support and monitoring.
  5. Ask A Vet provides comprehensive telehealth support from the acute phase through long-term management. 🐾

Dr Duncan Houston BVSc, founder of Ask A Vet. Download the Ask A Vet app today for remote guidance and support through your dog’s IMHA journey—from triage to treatment, monitoring, and prevention. 🐶📲

This article is general veterinary education and does not diagnose or treat an individual animal. Always confirm medication names, doses and interactions with the veterinarian who knows your pet.

If your animal is struggling to breathe, collapsed, bleeding heavily, seizing, or has eaten something toxic, contact your vet or the nearest emergency clinic now.

Animal Poisons Helpline (AU) 1300 869 738 · Animal Poisons Helpline (NZ) 0800 869 738 · ASPCA Animal Poison Control (US) (888) 426-4435

More from Ask A Vet

For everyday pet care, one scan or tap of the smart pet ID tag opens your pet's free profile on any phone, no app needed; the GPS pet tracker logs live location and activity trends; and the Ask A Vet app keeps your pet's records and routines together.

Try the calculatorHuman Years Calculator
Dr Duncan Houston
About the author
Dr Duncan Houston
Veterinarian · Founder of ASK A VET

Ask A Vet articles are written by Dr Duncan Houston BVSc, a practising veterinarian, unless another author is named in the byline.

Sign up for Ask A Vet news

Stay in the Pack

Get the latest news, vet-approved tips and early access to new gear — straight to your inbox.

By subscribing you consent to receive Ask A Vet marketing emails. Unsubscribe any time. See our Terms & Conditions and Privacy Policy. Your address is stored by Shopify and our email provider, Klaviyo.